X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6) 6
female (4) 4
index medicus (4) 4
male (4) 4
oncology (4) 4
adolescent (3) 3
adult (3) 3
aged (3) 3
alemtuzumab (3) 3
antineoplastic agents - therapeutic use (3) 3
beer (3) 3
biochemistry (3) 3
chemistry (3) 3
compositions or test papers therefor (3) 3
condition-responsive control in microbiological orenzymological processes (3) 3
disease-free survival (3) 3
enzymology (3) 3
health aspects (3) 3
human necessities (3) 3
hygiene (3) 3
leukemia, lymphocytic, chronic, b-cell - drug therapy (3) 3
measuring or testing processes involving enzymes, nucleicacids or microorganisms (3) 3
medical or veterinary science (3) 3
metallurgy (3) 3
microbiology (3) 3
middle aged (3) 3
mutation or genetic engineering (3) 3
neoplasm staging (3) 3
organic chemistry (3) 3
peptides (3) 3
preparations for medical, dental, or toilet purposes (3) 3
processes of preparing such compositions (3) 3
specific therapeutic activity of chemical compounds ormedicinal preparations (3) 3
spirits (3) 3
therapy (3) 3
vinegar (3) 3
wine (3) 3
adolescents (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized (2) 2
antibodies, neoplasm - therapeutic use (2) 2
campath-1h (2) 2
chlorambucil - therapeutic use (2) 2
cross-sectional studies (2) 2
follow-up studies (2) 2
gender differences (2) 2
high school students (2) 2
leukemia, lymphocytic, chronic, b-cell - pathology (2) 2
mechanisms (2) 2
nontraditional education (2) 2
prevalence (2) 2
public, environmental & occupational health (2) 2
risk factors (2) 2
schools (2) 2
activation (1) 1
aged, 80 and over (1) 1
alternative high schools (1) 1
anemia (1) 1
antibiotic (1) 1
antibodies (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, neoplasm - administration & dosage (1) 1
antibodies, neoplasm - adverse effects (1) 1
anticancer properties (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antitumor agents (1) 1
article (1) 1
at risk persons (1) 1
at risk students (1) 1
at risk youth (1) 1
at-risk youth (1) 1
b-cll (1) 1
bacteremia - chemically induced (1) 1
bacterial infections (1) 1
bacterial pneumonia (1) 1
barriers (1) 1
behaviors (1) 1
biochemistry & molecular biology (1) 1
bioindicators (1) 1
biomarkers (1) 1
body weight (1) 1
cancer (1) 1
cancer-research-network (1) 1
carboplatin (1) 1
carboplatin - adverse effects (1) 1
carboplatin - therapeutic use (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
carcinoma, non-small-cell lung - radiotherapy (1) 1
carcinoma, non-small-cell lung - surgery (1) 1
care and treatment (1) 1
cd8 t-cells (1) 1
cell biology (1) 1
chemotherapy (1) 1
children (1) 1
chlorambucil (1) 1
chlorambucil - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 13, pp. 1204 - 1213
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 1710 - 1710
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4_suppl, pp. 161 - 161
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. e15603 - e15603
Journal Article
by Lundqvist, Andreas and van Hoef, Vincent and Zhang, Xiaonan and Wennerberg, Erik and Lorent, Julie and Witt, Kristina and Sanz, Laia Masvidal and Liang, Shuo and Murray, Shannon and Larsson, Ola and Kiessling, Rolf and Mao, Yumeng and Sidhom, John-William and Bessell, Catherine A and Havel, Jonathan and Schneck, Jonathan and Chan, Timothy A and Sachsenmeier, Eliot and Woods, David and Berglund, Anders and Ramakrishnan, Rupal and Sodre, Andressa and Weber, Jeffrey and Zappasodi, Roberta and Li, Yanyun and Qi, Jingjing and Wong, Philip and Sirard, Cynthia and Postow, Michael and Newman, Walter and Koon, Henry and Velcheti, Vamsidhar and Callahan, Margaret K and Wolchok, Jedd D and Merghoub, Taha and Lum, Lawrence G and Choi, Minsig and Thakur, Archana and Deol, Abhinav and Dyson, Gregory and Shields, Anthony and Haymaker, Cara and Uemura, Marc and Murthy, Ravi and James, Marihella and Wang, Daqing and Brevard, Julie and Monaghan, Catherine and Swann, Suzanne and Geib, James and Cornfeld, Mark and Chunduru, Srinivas and Agrawal, Sudhir and Yee, Cassian and Wargo, Jennifer and Patel, Sapna P and Amaria, Rodabe and Tawbi, Hussein and Glitza, Isabella and Woodman, Scott and Hwu, Wen-Jen and Davies, Michael A and Hwu, Patrick and Overwijk, Willem W and Bernatchez, Chantale and Diab, Adi and Massarelli, Erminia and Segal, Neil H and Ribrag, Vincent and Melero, Ignacio and Gangadhar, Tara C and Urba, Walter and Schadendorf, Dirk and Ferris, Robert L and Houot, Roch and Morschhauser, Franck and Logan, Theodore and Luke, Jason J and Sharfman, William and Barlesi, Fabrice and Ott, Patrick A and Mansi, Laura and Kummar, Shivaani and Salles, Gilles and Carpio, Cecilia and Meier, Roland and Krishnan, Suba and McDonald, Dan and Maurer, Matthew and Gu, Xuemin and Neely, Jaclyn and Suryawanshi, Satyendra and Levy, Ronald and Khushalani, Nikhil and Wu, Jennifer and Zhang, Jinyu and Basher, Fahmin and Rubinstein, Mark and Bucsek, Mark and Qiao, Guanxi and ...
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 11/2016, Volume 4, Issue S1
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 919 - 919
Abstract Abstract 919 Background: Patients (pts) with Rai Stage III/IV CLL have a shorter median survival compared to Rai Stage I/II pts. We previously... 
Journal Article
Blood, ISSN 0006-4971, 11/2009, Volume 114, Issue 22, pp. 537 - 537
Abstract Abstract 537 Introduction: Single-arm pilot and Phase II trial data suggested that the combination of fludarabine and alemtuzumab (FluCam) may improve... 
Journal Article
Blood, ISSN 0006-4971, 11/2006, Volume 108, Issue 11, pp. 301 - 301
CAM307 is a phase III, open-label, multinational, randomized controlled trial comparing alemtuzumab (CAM) with chlorambucil (CHLO) for previously untreated... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.